Standard BioTools
LAB
LAB
138 hedge funds and large institutions have $269M invested in Standard BioTools in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 41 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
25% less call options, than puts
Call options by funds: $4.53M | Put options by funds: $6.01M
31% less capital invested
Capital invested by funds: $391M → $269M (-$123M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
138
Holding in Top 10
2
Calls
$4.53M
Puts
$6.01M
Top Buyers
| 1 | +$8.66M | |
| 2 | +$5.21M | |
| 3 | +$4.44M | |
| 4 |
SC
Samjo Capital
New York
|
+$3.68M |
| 5 |
O
OrbiMed
New York
|
+$3.2M |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$9.27M | |
| 3 | -$7.67M | |
| 4 |
GCM
Glenview Capital Management
New York
|
-$4.86M |
| 5 |
Renaissance Technologies
New York
|
-$4.47M |